Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' (Deficit) Equity

v3.22.1
Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Senior Subordinated Secured Convertible Note
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Convertible Preferred Stock
Common Stock
Common Stock
Common Class A And Common Class B
Common Stock
Common Class A And Common Class B
Senior Subordinated Secured Convertible Note
Additional Paid-in Capital
Additional Paid-in Capital
Senior Subordinated Secured Convertible Note
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Noncontrolling Interests
Beginning balance (in shares) at Jan. 31, 2019       102,408 82,805         13,376        
Beginning balance at Jan. 31, 2019 $ (26,203)   $ 31,880 $ 245,970 $ 3     $ 30,799   $ (17,957) $ (1,302) $ (283,716) $ 31,880 $ 7,099
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)         1,352                  
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 7,181             7,181           (7,181)
Stock-based compensation - equity classified awards 10,166             10,166            
Issuance of common stock under deferred stock compensation plan (in shares)         1,469                  
Exercise of stock options and release of vested restricted stock units 1,971             1,971            
Foreign currency translation adjustments 314                   314     (109)
Net loss (39,754)                     (39,754)   (27)
Ending balance (in shares) at Jan. 31, 2020       102,408 85,626         13,376        
Ending balance at Jan. 31, 2020 $ (14,445)   $ 31,880 $ 245,970 $ 3     50,117   $ (17,957) (988) (291,590)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accounting standards update, extensible enumeration Accounting Standards Update 2014-09                          
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)       19,902                    
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs $ 191,752     $ 191,752                    
Stock-based compensation - equity classified awards 44,159             44,159            
Issuance of common stock under deferred stock compensation plan (in shares)         9,572                  
Exercise of stock options and release of vested restricted stock units 16,333       $ 1     16,332            
Tender offer repurchases (in shares)       (1,407) (755)         755        
Tender offer repurchases (20,390)     $ (12,730)       (1,186)   $ (5,874)   (600)    
Issuance of Common Stock warrants 7,639             7,639            
Foreign currency translation adjustments (1,757)                          
Issuance of common stock to a third party (in shares)         1,013                  
Issuance of common stock to a third party 5,000             5,000            
Other comprehensive income (loss) 1,775                   1,775      
Net loss (37,970)                     (37,970)    
Ending balance (in shares) at Jan. 31, 2021       120,903 95,456 0       14,131        
Ending balance at Jan. 31, 2021 193,853     $ 424,992 $ 4 $ 0   122,061   $ (23,831) 787 (330,160)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)           18,288                
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 275,973             275,973            
Conversion of Senior subordinated secured convertible notes (in shares)       (120,903)   120,903 9,694              
Conversion of senior subordinated secured convertible notes 0 $ 82,114   $ (424,992)   $ 4   424,988 $ 82,114          
Stock-based compensation - equity classified awards 49,827             49,827            
Reclassification of common stock to Class B common stock (in shares)         (103,045) 103,045                
Reclassification of common stock to Class B common stock 0       $ (4) $ 4                
Issuance of common stock under deferred stock compensation plan (in shares)           1,770                
Exercise of stock options and release of vested restricted stock units (in shares)         7,589 1,999                
Exercise of stock options and release of vested restricted stock units 20,054             20,054            
Shares issued upon cashless exercise of common stock warrants (in shares)           230                
Issuance of common shares upon ESPP purchase (in shares)           552                
Issuance of common shares upon ESPP purchase $ 7,105             7,105            
Exercise of stock options (in shares) 9,421                          
Other comprehensive income (loss) $ (1,607)                   (1,607)      
Net loss (111,470)                     (111,470)    
Ending balance (in shares) at Jan. 31, 2022       0 0 256,481       14,131        
Ending balance at Jan. 31, 2022 $ 515,849     $ 0 $ 0 $ 8   $ 982,122   $ (23,831) $ (820) $ (441,630)